Natera (NTRA) Chairman Matthew Rabinowitz Sells $11M of Stock
Matthew Rabinowitz parted with 50,000 shares of Natera, Inc. on June 15, 2026, totaling roughly $10.7 million in a planned transaction.
Reviewed by automated data checks against the source filing. How we make and check alerts
Matthew Rabinowitz, EXECUTIVE CHAIRMAN at Natera, Inc. ($NTRA), sold 50,000 shares at an average price of $214.91, worth about $10.75 million, on June 15, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.
Since the trade, $NTRA is up 5.5% after 1 week, up 27.8% after 1 month and up 81.3% to date (from the $216.97 close on Jun 15, 2026).
NTRA
Natera, Inc.
Key Points
- Natera, Inc. Executive Chairman Matthew Rabinowitz sold 50,000 shares of stock on June 15, 2026, at an average price of $214.91 per share.
- The transaction brought in roughly $10.75 million and was executed under a pre-arranged trading plan.
- Other corporate insiders, including Daniel Rabinowitz and Rowan Chapman, have also transacted in Natera shares around the same period.
Get $NTRA trade alerts by text
We text you when insiders, Congress or big funds trade $NTRA. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Natera, Inc. alert may contain errors. Disclosures
Executive Chairman Matthew Rabinowitz Sells Natera Shares
Natera, Inc. (NasdaqGS: NTRA) Executive Chairman Matthew Rabinowitz sold 50,000 shares of the company on June 15, 2026. The shares were disposed of at an average price of $214.91, bringing the total value of the transaction to approximately $10.75 million. The move was executed under a pre-arranged trading plan, allowing company insiders to sell shares according to a set schedule without running afoul of insider trading rules.
Insider Buying and Selling at Natera, Inc.
This sale adds to recent insider activity across Natera. On June 24, 2026, Secretary and Chief Legal Officer Daniel Rabinowitz sold 33,600 shares at an average price of $251.65 for a total value of about $8.46 million in a planned move. Around the same time, several other insiders made smaller purchases. Rowan Chapman acquired 1,674 shares on June 26, 2026, while Thomas Lynch JR. bought 1,905 shares on the same day. Additional purchases on June 26 included 1,691 shares by Roelof Botha, 75 shares by Eric Rubin, and 1,646 shares by Roy Baynes.
NTRA Stock Performance and Context
Trading around $225.94 on Wednesday, Natera shares sit well within their 52-week range of $157.43 to $373.07. The diagnostics company carries a market capitalization of roughly $53.4 billion. Because the company is not currently profitable on a trailing basis, it does not feature a meaningful positive P/E ratio, though analysts maintain a strong consensus on its growth potential in molecular testing.
Analysts Set New Price Targets
Wall Street firms remain largely positive on the diagnostics specialist. On October 14, 2026, JP Morgan maintained an Overweight rating on NTRA while raising its price target to $460 from $360. Earlier in October, TD Cowen reaffirmed a Buy rating with a target of $480, and Barclays kept its Overweight rating with a target of $475. The stock currently holds a consensus recommendation of strong_buy among analysts, with a mean price target of $348.02.
Inside the Business
Natera, Inc. is a diagnostics company headquartered in Austin, Texas, focusing on the development and commercialization of molecular testing services. Its portfolio includes Signatera for personalized ctDNA blood testing in cancer monitoring, Panorama for non-invasive prenatal testing, and various hereditary and organ transplant screening options. The company serves medical centers, reference labs, and pharmaceutical partners worldwide.
What to Watch at Natera, Inc.
Investors will look ahead to Natera's next earnings report, scheduled for November 5, 2026, to gauge ongoing revenue growth and progress toward profitability. Insiders may continue to execute planned transactions under their respective trading schedules, and further SEC filings will track any changes in leadership holdings.
Related Filing Alerts
Source: Matthew Rabinowitz's Form 4 filing on $NTRA (Jun 15, 2026). Find the original filing: NTRA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts